Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |